Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016· article· en· New England Journal of Medicine· Medicine
aff
10 101
citations
Travaux
Tous les travaux de la base. Chaque rangée indique les voies par lesquelles le travail a été admis, car une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée.
Voie
Domaine
Type
Langue
Période
à
Consensus du tri
Ordre
Indicateurs
Données de dépistage
Les étiquettes directes sont rares et non validées. Une absence reste inconnue.
1 filtre actif
10 000+ travauxpage 1
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
2018· article· en· New England Journal of Medicine· Medicine
aff
6 613
citations
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
2016· article· en· JAMA Oncology· Medicine
aff
6 310
citations
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
2015· article· en· New England Journal of Medicine· Medicine
aff
6 228
citations
5 830
citations
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005· article· en· New England Journal of Medicine· Medicine
aff
5 451
citations
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014· article· en· Nature Communications· Medicine
affsans résumé
5 145
citations
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
2016· article· en· Journal of Thoracic Oncology· Medicine
affsans résumé
4 643
citations
The 2015 World Health Organization Classification of Lung Tumors
2015· editorial· en· Journal of Thoracic Oncology· Medicine
affsans résumé
4 546
citations
Comprehensive genomic characterization of squamous cell lung cancers
2012· article· en· Nature· Biochemistry, Genetics and Molecular Biology
afffund
4 016
citations
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
2007· article· en· Journal of Thoracic Oncology· Medicine
affsans résumé
3 678
citations
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
2005· article· en· PLoS Medicine· Medicine
fundno aff
3 526
citations
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016· article· en· New England Journal of Medicine· Medicine
aff
3 329
citations
Surgeon Volume and Operative Mortality in the United States
2003· article· en· New England Journal of Medicine· Medicine
aff
3 100
citations
Genes that mediate breast cancer metastasis to lung
2005· article· en· Nature· Medicine
affsans résumé
2 957
citations
Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC
2019· article· en· New England Journal of Medicine· Medicine
aff
2 816
citations
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008· article· en· Journal of Clinical Oncology· Medicine
aff
2 670
citations
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013· article· en· Journal of Clinical Oncology· Medicine
afffundabout
2 658
citations
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
2017· letter· en· New England Journal of Medicine· Medicine
aff
2 575
citations
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004· article· en· Journal of Clinical Oncology· Medicine
aff
2 433
citations
Comprehensive genomic profiles of small cell lung cancer
2015· article· en· Nature· Medicine
affsans résumé
2 386
citations
Metastatic Behavior of Breast Cancer Subtypes
2010· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
aff
2 284
citations
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
2015· article· en· The Lancet Oncology· Medicine
affsans résumé
2 007
citations
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005· article· en· New England Journal of Medicine· Medicine
aff
1 854
citations
Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
2005· article· en· New England Journal of Medicine· Medicine
aff
1 832
citations